Alloy Therapeutics appoints Venkat Krishnamurthy as chief scientific officer of genetic medicines unit
read at STAT ↗Neutral
Alloy Therapeutics announced the hiring of Venkat Krishnamurthy as chief scientific officer for its genetic medicines division.
Krishnamurthy previously held the same role at Flashpoint Therapeutics, where he oversaw the development of genetic therapy programs.
The move reflects Alloy's focus on bolstering its leadership as the genetic medicines sector continues to expand.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Up and down the ladder: The latest comings and goings”
read at STAT ↗448 words · retrieved Sep 11
comments(0)
5-min edit window · permanent after that